Astrazeneca Pharma India's Stock Reaches All-Time High, Outperforms Sector by 11.06%

Astrazeneca Pharma India, a midcap pharmaceutical company, has been making headlines in the stock market as its share price reached an all-time high on September 24, 2024. The stock, which is currently trading at Rs 7550, is just 0.58% away from its 52-week high.

According to MarketsMOJO, a leading stock market analysis and research platform, the stock is currently rated as a 'Hold'. This comes as the company's performance today has outperformed the sector by 11.06%. The stock also opened with a gain of 2.24% today and touched an intraday high of Rs 7549.95, which is 11.87% higher than its previous close.

In terms of moving averages, Astrazeneca Pharma India is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend in the stock's performance.

In the past year, Astrazeneca Pharma India has shown a remarkable growth of 65.14%, outperforming the Sensex's performance of 28.64%. This showcases the company's strong performance and potential for growth in the pharmaceutical industry.

With its consistent growth and positive performance, Astrazeneca Pharma India continues to be a promising midcap company in the pharmaceutical sector. Investors can keep a close eye on this stock as it continues to make strides in the market.